• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Coagulation factor X (F10)

ACP22134

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP22134 Target NameF10
Target SynonymsActivated factor Xa heavy chain; Coagulation factor X ; F10; FA10_HUMAN; FX ; FXA; Prothrombinase ; Stuart factor; Stuart Prower factor; Stuart-Prower factorFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range41-488
Protein LengthFull Length of Mature ProteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP00742
Background Information
  • Uniprot Id

    P00742

  • Target Species

    Human

  • Target Name

    F10

  • Target Full Name

    Coagulation factor X

  • Target Function

    Factor Xa is a vitamin K-dependent glycoprotein that converts prothrombin to thrombin in the presence of factor Va, calcium and phospholipid during blood clotting.

  • Target Involvement

    Factor X deficiency (FA10D)

  • Target Subcellular Location

    Secreted.

  • Target Protein Families

    Peptidase S1 family

  • Target Tissue Specificity

    Plasma; synthesized in the liver.

  • Target Research Area

    Signal Transduction

  • Target Synonyms

    Activated factor Xa heavy chain; Coagulation factor X ; F10; FA10_HUMAN; FX ; FXA; Prothrombinase ; Stuart factor; Stuart Prower factor; Stuart-Prower factor

  • Target Background

    This gene encodes the vitamin K-dependent coagulation factor X of the blood coagulation cascade. This factor undergoes multiple processing steps before its preproprotein is converted to a mature two-chain form by the excision of the tripeptide RKR. Two chains of the factor are held together by 1 or more disulfide bonds; the light chain contains 2 EGF-like domains, while the heavy chain contains the catalytic domain which is structurally homologous to those of the other hemostatic serine proteases. The mature factor is activated by the cleavage of the activation peptide by factor IXa (in the intrisic pathway), or by factor VIIa (in the extrinsic pathway). The activated factor then converts prothrombin to thrombin in the presence of factor Va, Ca+2, and phospholipid during blood clotting. Mutations of this gene result in factor X deficiency, a hemorrhagic condition of variable severity. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing to generate mature polypeptides.

Inquire Recombinant Human Coagulation factor X (F10) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification